Figure 8.Drug sensitivity analysis. The sensitivity of 5-Fluorouracil (A), cisplatin (B), gemcitabine (C), irinotecan (D), KRAS (G12C) inhibitor-12 (E), oxaliplatin (F), paclitaxel (G), and trametinib (H) between the high and low ERS score groups. (I) Correlation of drug sensitivity and MET, KRT7, and MUC16 expression.
